Refractory Digital Ulcers in Systemic Sclerosis Sine Scleroderma Associated With Antiphospholipid Syndrome: A Case-Based Review
Abstract
Digital ulcers (DUs) are a severe manifestation of the vasculopathy underlying systemic sclerosis (SSc). In cases refractory to treatment, the presence of other modifiable causes of vasculopathy, such as antiphospholipid syndrome (APS), should be considered, although its diagnosis in patients with systemic sclerosis sine scleroderma (ssSSc) is exceedingly rare. We report the case of a 20-year-old Caucasian female with ssSSc, who presented with Raynaud's phenomenon (RP), recurrent DU, telangiectasias, inflammatory arthralgias, dyspepsia, and epigastric pain, in the absence of skin thickening. Laboratory investigation revealed a high-titre antinuclear antibody (ANA; 1:2560) with an anti-centromere pattern, and positivity for both anti-centromere antibodies (ACA) and anti-Ro-52 antibodies. Nailfold capillaroscopy showed an early scleroderma pattern. Despite optimized vasodilatory therapy, including calcium channel blockers, phosphodiesterase inhibitors, endothelin receptor antagonists, and regular iloprost infusions, the patient continued to experience recurrent DU. Following a pulmonary embolism with lingula infarction, anticoagulation was initiated, resulting in complete healing of the DU within two months and no subsequent thrombotic events. Repeat testing confirmed persistent positivity for lupus anticoagulant (LA) and anti-β2-glycoprotein I (anti-β2GPI) IgG more than 12 weeks apart, establishing the diagnosis of secondary APS. To our knowledge, this is the fourth reported…
How strong is the evidence?
Evidence Hub reads this as a case report, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.
Read the paper
Related studies
- Drug repositioning: a brief overview
- Cyclic nucleotide phosphodiesterases in Drosophila melanogaster
- Time-resolved in silico modeling of fine-tuned cAMP signaling in platelets: feedback loops, titrated phosphorylations and pharmacological modulation
- Current View on Green Tea Catechins Formulations, Their Interactions with Selected Drugs, and Prospective Applications for Various Health Conditions
- In silico Structure-based Identification of Novel Acetylcholinesterase Inhibitors Against Alzheimer’s Disease
- Development and In Vitro Evaluation of Controlled Release Viagra® Containing Poloxamer-188 Using Gastroplus™ PBPK Modeling Software for In Vivo Predictions and Pharmacokinetic Assessments
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.